The impact of cannabis use on patients enrolled in opioid agonist therapy in Ontario, Canada

por Franklyn, Alexandra M., Eibl, Joseph K., Gauthier, Graham J., Marsh, David C.
Publicado 2017

The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario

por Franklyn, Alexandra M., Eibl, Joseph K., Gauthier, Graham, Pellegrini, David, Lightfoot, Nancy K., Marsh, David C.
Publicado 2017

Erratum to: The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario

por Franklyn, Alexandra M., Eibl, Joseph K., Gauthier, Graham, Pellegrini, David, Lightfoot, Nancy E., Marsh, David C.
Publicado 2017

A cohort study evaluating the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention for patients in opioid agonist treatment (OA...

por Morin, Kristen A., Eibl, Joseph K., Gauthier, Graham, Rush, Brian, Mushquash, Christopher, Lightfoot, Nancy E., Marsh, David C.
Publicado 2020

Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada

por Morin, Kristen A., Eibl, Joseph K., Caswell, Joseph M., Gauthier, Graham, Rush, Brian, Mushquash, Christopher, Lightfoot, Nancy E., Marsh, David C.
Publicado 2019

Correction to: Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada

por Morin, Kristen A., Eibl, Joseph K., Caswell, Joseph M., Gauthier, Graham, Rush, Brian, Mushquash, Christopher, Lightfoot, Nancy E., Marsh, David C.
Publicado 2019